rediff.com
X   
REAL-TIME QUOTE
Enter Company or MF
e.g. Tata motors, Reliance MF, 500570
Refresh

500124 DRREDDY Group (A)

Dr. Reddy's Laboratories Ltd. LIVE on BSE (View NSE)   

Add to watchlist
 
Zoom
2130.50   -22.40   -1.04%
Volume 9,643
Prev close 2,152.90
Day's H/L (Rs.) 2,150.00 - 2,121.00
52wk H/L (Rs.) 2,207.80 - 1,528.00
Mkt Cap (Rs. Cr) 36,175.89
HOW HOT IS THIS STOCK?

Last 15 days data © Rediff.com
Refresh

DRREDDY

Dr. Reddy's Laboratories Ltd. LIVE on NSE (View BSE)   

Add to watchlist
 
Zoom
2133.25   -13.20   -0.61%
Volume 189,805
Prev close 2146.45
Day's H/L (Rs.) 2,150.00 - 2,120.00
52wk H/L (Rs.) 2,207.15 - 1,526.40
Turnover (Rs. Lacs) 4,050.21
HOW HOT IS THIS STOCK?

Last 15 days data © Rediff.com

Realtime news for Dr. Reddy's Laboratories Ltd. (See all 650 news)

19 June 2013, 11:58
Dr Reddy's sued for thyroid patent infringement - 16 min(s) ago
Dr Reddys and Fujifilm call off JV for generic drugs in Japan - 1 day(s) ago
A company can't depend on one person: Dr Reddy's Labs' GV Prasad - 1 day(s) ago
Dr Reddys, Divis Labs to get astro support: Satish Gupta - 2 day(s) ago
Strong US growth to boost pharm cos' fortune in FY14 - 12 Jun 2013

Market Voices for Dr. Reddy's Laboratories Ltd.  (See all 97 market voices)   

140 Characters
  Cancel
Expert Voices - 04 Jun 2013
#Dr-Reddy-s-Laboratories-Ltd
 launches Zenatane in the US, say reports. (NDTV Profit)
#money
Reply   |   Share
ronin bond - 2 weeks ago  Sell tgt 1983 within dis friday -nifty operator call
Reply   |  Share
dhankhar - 2 weeks ago  good stock and now good level buy..now target 297 with in 5 days buy raymond ltd.
Reply   |  Share
Rkg - 07 Jun 2013 csl : 2085 ; tgt : 2190 / 2200
#Dr-Reddy-s-Laboratories-Ltd
#money
Reply   |   Share
dhankhar - 2 weeks ago  Buy Raymond with a target of Rs 321: Ashwani Gujral
Reply   |  Share
rkg - 1 week ago  bkd at 2199
Reply   |  Share

BSE Announcements from Dr. Reddy's Laboratories Ltd. (See all)

Disclosures under Reg.13(6) of SEBI (Prohibition of Insider Trading) Regulations, 1992 - 6 day(s) ago
Disclosures under Reg. 29(1) and 29(2) of SEBI (SAST) Regulations, 2011 - 10 Jun 2013

Company details for Dr. Reddy's Laboratories Ltd.

Report Card

PE Ratios
29.21
EPS (Rs.)
74.51
Sales (Rs. Cr)
2,362.48
Face Value (Rs.)
5
Net Profit
Margin (%)
 
13.51
Last Bonus
1:1
Last Dividend(%)
300
Return on
Average Equity
 
13.58

Research Centre

Results: Quarterly  |  Half Yearly  |  Annual
Statements: Balance Sheet  |  P&L  |  Cash Flow  More: Dividend  |  Bonus  |  Share Holding  |  Capital Structures  |  Ratios

Mutual Funds Invested

Dr. Reddy's Laboratories Ltd. performance snapshot

If you had invested Rs.  in Dr. Reddy's Laboratories Ltd.,   ago

You would have  Rs. 000.00 

Add to portfolio

Compare Dr. Reddy's Laboratories Ltd. with other stocks

Cadila Healthcare Ltd.
752.60
Compare
GlaxoSmithKline Pharmaceuticals Ltd.
2,430.50
Compare
Show more companies
Cadila Healthcare Ltd.
752.60
Compare
GlaxoSmithKline Pharmaceuticals Ltd.
2,430.50
Compare
Divi's Laboratories Ltd.
970.75
Compare
Aurobindo Pharma Ltd.
169.60
Compare
Cipla Ltd.
377.95
Compare
Apollo Hospitals Enterprise Ltd.
991.50
Compare
Ipca Laboratories Ltd.
646.85
Compare
Lupin Ltd.
783.20
Compare
Piramal Enterprises Ltd.
533.80
Compare
Sun Pharmaceutical Industries Ltd.
952.85
Compare
Show less companies

ALL MONEYWIZ PAGES

rediff on the net© 2013 Rediff.com India Limited. All rights reserved. Disclaimer - Terms of Service - Privacy Policy - Feedback
Close
Add Dr. Reddy's Laboratories Ltd. to your Portfolio
 
 
 
*Portfolio will be calculated based on BSE values
Close
Add Dr. Reddy's Laboratories Ltd. to your Watchlist
Alert me if price...
*Watchlist will be based on BSE values
Close